Collaborative research into outcome measures in Sjögren's syndrome

References

• Moutsopoulos HM, Chused TM, Mann DL et al Sjogren's syndrome [sicca syndrome): current issues. Annals Intern Med 1980;92:212–26.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheum 2000;29:341–8.
   Google Scholar
• Vivino FB. The treatment of Sjogren's syndrome patients with pilocarpine-tablets. Scand J Rheumatol 2001;30 Suppl 115: 1–13.
   PubMed Web of Science ®Google Scholar
• Anonymous. Cevimeline (Evoxac) for dry mouth. The Medical Letter on Drugs and Therapeutics 2000;1084:70.
   Google Scholar
• Gunduz K, Ozdemir 0. Topical cyclosporine treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta Ophthalmol (Copenh) 1994;72: 438–42.
   Google Scholar
• Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB. Treatment of primary Sjogren's syndrome with low-dose natural interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. J Interferon Cytokine Res 1999;19:943–51.
   Google Scholar
• Shiozawa S, Tanaka Y, Shiozawa K. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerosto-mia in patients with Sjogren's syndrome. J Interferon Cytokine Res 1998;18:255–62.
   Google Scholar
• Vitali C, Bombardieri S. The European classification criteria for Sjogren's syndrome (SS). Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROC) curve of the criteria performance. J Rheumatol 1997;24:550.
   Google Scholar
• Wolfe F, Lassere M, van der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:484–9.
   Google Scholar
• Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: con-sensus on a preliminary core set of outcome domains. J Rheumatol 1999;26:504–7.
   PubMed Web of Science ®Google Scholar
• Martens PB, Pillemer SR, Jacobsson LT, O'Fallon WM, Matteson EL. Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976–1992. J Rheumatol 1999;26: 1296–300.
   Google Scholar
• Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107–18.
   PubMed Web of Science ®Google Scholar
• Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363–9.
   PubMed Web of Science ®Google Scholar
• Kruize AA, Hene RJ, Kallenberg CGM, van Bijsterveld OP, van der Heide A, Kater L, et al. Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993;52:360–4.
   Google Scholar
• Fox RI, Guarrasi V, Krubel S. Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 1996;5 Suppl 1:S31–S36.
   Google Scholar
• Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 1999;58:253–6.
   PubMed Web of Science ®Google Scholar
• Vitali C, ed. Proceedings from Workshop on Diagnostic Criteria for Sjogren's Syndrome. Clin Exp Rheumatol 1989;7 Supp1:111–218.
   Google Scholar
• Gannot G, Lancaster HE, Fox PC. Clinical course of primary Sjogren's syndrome: salivary, oral and serologic aspects. J Rheumatol 2000;27:1905–9.
   Google Scholar
• Davidson BKS, Kelly CA, Griffiths ID. Primary Sjogren's syndrome in the North East of England: a long-term follow-up study. Rheumatology 1999;38: 245–53.
   Google Scholar
• Asmussen K, Anderson V, Bendixen G, Bendtzen K, Prause JU, Thorn J, et al. Quantitative assessment of clinical disease status in primary Sjogren's syndrome. Scand J Rheumatol 1997;26:197–205.
   PubMed Web of Science ®Google Scholar
• Oxholm P, Asmussen K, Axell T, van Bijsterveld OP, Jacobsson L, Konttinen Y, et al. Sjogren's syndrome: termino-logy. Clin Exp Rheumatol 1995;13:693–6.
   Google Scholar
• Manthorpe R, Asmussen K, Oxholm P. Primary Sjogren's syndrome: diagnostic criteria, clinical features, and disease activity. J Rheumatol 1997;24 Suppl 50:8–11.
   Google Scholar
• Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus eryth-ematosus [SLE), SLE and Sjogren's syndrome [ SS), and primary SS. J Rheumatol 1998;25:63–8.
   PubMed Web of Science ®Google Scholar
• Bowman ST Pillemer S, Jonsson R, Asmussen K, Vitali C, Manthorpe R, et al. Revisiting Sjogren's syndrome in the new millenium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatology 2001;40: 1180 —8.
   Google Scholar
• Asmussen KH, Bowman SJ. Outcome measures in Sjogren's syndrome. Rheumatology 2001;40:1085 —8.
   Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615 —21.
   Google Scholar
• Rostron J, Field A et al. Development of a disease-specific, health-related QOL measure for primary Sjogren's syndrome [in preparation).
   Google Scholar
• Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998;57:20–4.
   PubMed Web of Science ®Google Scholar
• Chalder T, Berelowitx G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosomatic Res 1993;37:147–53.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory [MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315 —25.
   Google Scholar
• Piper BF, Lindsey AM, Dodd MJ, Ferketich S, Paul SM, Weller, S. The development of an instrument to measure the subjective dimension of fatigue. In: Funk S, Tornquist E, Champagne M, Copp L, Wierse R, eds. Key aspects of comfort. New York: Springer 1989:199–208.
   Google Scholar
• Schwartz JE, Jandorf L, Krupp L.B. The measurement of fatigue: a new instrument. J Psychosomatic Res 1993;37:753 —62.
   Google Scholar
• Wahren M, Tengner P, Gunnarsson I, Lundberg I, Hedfors E, Ringertz NR, Pettersson I. Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and sys-temic lupus erythematosus. J Autoimmun 1998;11:29 —38.
   Google Scholar
• Booth DA, Platts RG, Bowman SJ, et al. Descriptors of fatigue and pain in rheumatoid arthritis, lupus and Sjogren's syndrome. (Submitted 2001).
   Google Scholar